Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models

References

• Arndt D., Fichtner I. Recent results in the liposomal encapsulation of mitoxantrone. Poster presentation at Conference of Liposomes and Drug Delivery 21 Years on, London, 1990
   Google Scholar
• Beck P., Scherer D., Kreuter J. Separation of drug‐loaded nanoparticles from free drug by gel filtration. Journal of Microencapsulation 1990; 7: 491–496
   PubMed Web of Science ®Google Scholar
• Brasseur F., Couvreur P., Kante B., Deckers‐Passau L., Roland M., Deckers C., Speiser P. Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumour. European Journal of Cancer 1980; 16: 1441–1445
   PubMed Web of Science ®Google Scholar
• Burns C. P., Haugstad B. N., Mossmann C. J., North J. A., Ingraham L. M. Membrane lipid alteration: effect on cellular uptake of mitoxantrone. Lipids 1988; 23: 393–397
   PubMedGoogle Scholar
• Couvreur P., Kante B., Grislain L., Roland M., Speiser P. Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin‐loaded nanoparticles. Journal of Pharmaceutical Sciences 1982; 71: 790–792
   PubMed Web of Science ®Google Scholar
• Couvreur P., Kante B., Lenaerts V., Scailteur V., Roland M., Speiser P. Tissue distribution of antitumour drugs associated with polyalkylcyanoacrylate nanoparticles. Journal of Pharmaceutical Sciences 1980; 69: 199–202
   PubMed Web of Science ®Google Scholar
• Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. Journal of Pharmacy and Pharmacology 1979a; 31: 331–332
   PubMed Web of Science ®Google Scholar
• Couvreur P., Kante B., Roland M., Speiser P. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. Journal of Pharmaceutical Sciences 1979b; 68: 1521–1524
   PubMed Web of Science ®Google Scholar
• Diepold R., Kreuter J., Himber J., Gurny R., Lee V. H. L., Robinson J. R., Saettone M. F., Schnaudigel O. E. Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). Graefe's Archive of Clinical and Experimental Ophthalmology 1989; 227: 188–193
   PubMed Web of Science ®Google Scholar
• Douglas S. J., Davis S. S., Illum L. Biodistribution of poly‐(butyl 2‐cyanoacrylate) nanoparticles in rabbits. International Journal of Pharmaceutics 1986; 34: 145–152
   Web of Science ®Google Scholar
• Douglas S. J., Illum L., Davis S. S. Poly(butyl 2‐cyanoacrylate) nanoparticles with differing surface charges. Journal of Controlled Release 1986; 3: 15–23
   Google Scholar
• Drewinko B., Yang L. ‐Y., Barlogie B., Trujillo J. M. Comparative cytotoxicity of bis‐antrene, mitoxantrone, ametantrone dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro. Cancer Research 1983; 43: 2648–2653
   PubMedGoogle Scholar
• Durr F. E. Biologic and biochemical effects of mitoxantrone. Seminars in Oncology 1984; 11(Suppl. 1)3–10
   PubMedGoogle Scholar
• El Egakey M. A., Speiser P. Drug loading studies on ultrafine solid carriers by sorption procedures. Pharmaceutica Acta Helvetiae 1982; 57: 236–240
   PubMedGoogle Scholar
• Fichtner I., Arndt D. Stand und Perspektiven der Liposomenforschung. Die Pharmazie 1989; 44: 752–757
   PubMed Web of Science ®Google Scholar
• Fichtner I., Arndt D., Reszka R. Pharmacological effects of mitoxantrone liposomes in murine tumour models. Lecture at 3rd International Conference of Anticancer Research, Marathon. 1990
   Google Scholar
• Gipps E. M., Arshady R., Kreuter J., Groscurth P., Speiser P. Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma. Journal of Pharmaceutical Sciences 1986; 75: 256–258
   PubMed Web of Science ®Google Scholar
• Illum L., Davis S. S. Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. Journal of Pharmaceutical Sciences 1983; 72: 1086–1089
   PubMed Web of Science ®Google Scholar
• Illum L., Hunneyball I. M., Davis S. S. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. International Journal of Pharmaceutics 1986; 29: 53–65
   Web of Science ®Google Scholar
• Illum L., Khan M. A., Mak E., Davis S. S. Evaluation of carrier capacity and release characteristics for poly(butyl‐2‐cyanoacrylate) nanoparticles. International Journal of Pharmaceutics 1986; 30: 17–28
   Web of Science ®Google Scholar
• Johnson R. K., Zee‐Cheng R. K.‐Y., Lee W. W., Acton E. M., Henry D. W., Cheng C. C. Experimental antitumour activity of anthraquinones. Cancer Treatment Report 1979; 63: 425–439
   PubMedGoogle Scholar
• Juliano R. L., Stamp D. Pharmacokinetics of liposome‐encapsulated anti‐tumour drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin. Biochemical Pharmacology 1978; 27: 21–27
   PubMed Web of Science ®Google Scholar
• Kante B., Couvreur P., Lenaerts V., Guiot P., Roland M., Baudhuin P., Speiser P. Tissue distribution of [3H]actinomycin D adsorbed on polybutylcyanoacrylate nanoparticles. International Journal of Pharmaceutics 1980; 7: 45–53
   Google Scholar
• Kante B., Couvreur P., Dubois‐Krack G., De Meester C., Guiot P., Roland M., Mercier M., Speiser P. Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles. Journal of Pharmaceutical Sciences 1982; 71: 786–790
   PubMed Web of Science ®Google Scholar
• Kimelberg H. K. Differential distribution of liposome‐entrapped [3H]methotrexate and labelled lipids after intravenous injection in a primate. Biochimica et Biophysica Acta 1976; 448: 531–550
   PubMedGoogle Scholar
• Kreuter J. Evaluation of nanoparticles as drug‐delivery systems. I: Preparation methods. Pharmaceutica Acta Helvetiae 1983a; 58: 196–209
   Google Scholar
• Kreuter J. Evaluation of nanoparticles as drug‐delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter ± 1μm), liposomes and emulsions. Pharmaceutica Acta Helvetiae 1983b; 58: 217–226
   PubMedGoogle Scholar
• Kreuter J. Evaluation of nanoparticles as drug‐delivery systems. III: Materials, stability, toxicity, possibilities of targeting, and use. Pharmaceutica Acta Helvetiae 1983c; 58: 242–250
   PubMedGoogle Scholar
• Kreuter J. Factors influencing the body distribution of polyacrylic nanoparticles. Drug Targeting, P. Buri, A. Gumma. Elsevier, Amsterdam 1985; 51–63
   Google Scholar
• Kreuter J., Hartmann H. R. Comparative study on the cytostatic effects and the tissue distribution of 5‐fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180‐bearing mice. Oncology 1983; 40: 363–366
   PubMed Web of Science ®Google Scholar
• Lenaerts V., Couvreur P., Christiaens‐Leyh D., Joiris E., Roland M., Rollman B., Speiser P. Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials 1984; 5: 65–68
   PubMed Web of Science ®Google Scholar
• Leu D., Manthey B., Kreuter J., Speiser P., DeLuca P. P. Distribution and elimination of coated polymethyl[2‐14C]‐methacrylate nanoparticles after intravenous injection in rats. Journal of Pharmaceutical Sciences 1984; 73: 1433–1437
   PubMed Web of Science ®Google Scholar
• Lu K., Savaray N., Loo T. L. Pharmacological disposition of 1,4‐dihydroxy‐5,8‐bis[[2‐[(2‐hydroxyethyl)amino]ethyl]‐amino]‐9,10‐anthracenedione dihydrochloride in the dog. Cancer Chemotherapy and Pharmacology 1984; 13: 63–66
   PubMed Web of Science ®Google Scholar
• Mann H. B., Whitney D. R. On a test of whether one of two random variables is stochastically larger than the other. Annals of Mathematical Statistics 1947; 18: 50–60
   Google Scholar
• Maral R., Bourut C., Chenu E., Mathe G., Bernon R., Lussan C., Imbach J. L., Schein P., Bothorel P. Comparison of the experimental antitumour activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state. Oncology 1985; 42: 122–128
   PubMedGoogle Scholar
• New R. R. C., Black C. D. V., Parker R. J., Puri A., Scherphof G. L. Liposomes in biological systems. Liposomes—a Practical Approach, R. R. C. New. IRL Press, Oxford 1990; 221–252
   Google Scholar
• Reszka R., Fichtner I., Nissen E., Arndt D., Ladhoff A. ‐M. Preparation, characterization, therapeutic efficacy and toxicity of liposomes, containing the antitumour drug cis‐dichlorodiamineplatinum(II). Journal of Microencapsulation 1987; 4: 201–212
   PubMed Web of Science ®Google Scholar
• Sachs L. Angewandte Statistik6. Auflage. Springer‐Verlag, Heidelberg 1984; 230–240
   Google Scholar
• Schwendener R. A., Fiebig H. H., Berger M. R., Berger D. P. Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumour efficacy. Cancer Chemotherapy and Pharmacology 1991; 27: 429–439
   PubMed Web of Science ®Google Scholar
• Shenkenberg T. D., Von Hoff D. D. Mitoxantrone: a new anticancer drug with significant clinical activity. Annals of International Medicine 1986; 105: 67–81
   PubMed Web of Science ®Google Scholar
• Smith I. E. Mitoxantrone (Novantrone): a review of experimental and early clinical studies. Cancer Treatment Reviews 1983; 10: 103–115
   PubMed Web of Science ®Google Scholar
• Storm G., Roerdink F. H., Steerenberg P. A., DeJong W. H., Crommelin D. J. A. Influence of lipid composition on the antitumour activity exerted by doxorubicin‐containing liposomes in a rat solid tumour model. Cancer Research 1987; 47: 3366–3372
   PubMed Web of Science ®Google Scholar
• Stuart‐Harris R. C., Bozek T., Pavlidis N. A., Smith I. E. Mitoxantrone: an active new agent in the treatment of advanced breast cancer. Cancer Chemotherapy and Pharmacology 1984; 12: 1–4
   PubMed Web of Science ®Google Scholar
• Thomas J. C. The determination of log normal particle size distributions by dynamic light scattering. Journal of Colloid and Interface Science 1987; 117: 187–192
   Web of Science ®Google Scholar
• Tröster S. D., Kreuter J. Influence of the surface properties of low contact angle surfactants on the body distribution of 14C‐poly(methyl methacrylate) nanoparticles. Journal of Microencapsulation 1992; 9: 19–28
   PubMed Web of Science ®Google Scholar
• Tröster S. D., Müller U., Kreuter J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. International Journal of Pharmaceutics 1990; 61: 85–100
   Web of Science ®Google Scholar
• Vauthier‐Holtzscherer C., Benabbou S., Spenlehauer G., Veillard M., Couvreur P. Methodology for the preparation of ultra‐dispersed polymer systems. STP Pharma Sciences 1991; 1: 109–116
   Google Scholar
• Wagner J. Teilchengröße‐Bestimmung mittels dynamischer Lichtstreuung. Chemie‐Ingenieur‐Technik 1986; 58: 578–583
   Google Scholar
• Weiner N., Martin F., Riaz M. Liposomes as drug delivery system. Drug Development and Industrial Pharmacy 1989; 15: 1523–1554
   Web of Science ®Google Scholar